Standout Papers

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes 2018 2026 2020 2023 4.1k
  1. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes (2018)
    Stephen D. Wiviott, Itamar Raz et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 122 standout
Sub-graph 1 of 12

Citing Papers

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
2024 Standout
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
2022 Standout
57 intermediate papers

Works of Itamar Raz being referenced

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
2016
and 1 more

Author Peers

Author Last Decade Papers Cites
Itamar Raz 3862 1565 1554 9 4.5k
Gordon Law 5004 2081 2058 12 6.1k
Stuart Warren 3245 931 798 22 5.4k
Martin Fredriksson 3695 1507 1604 46 4.7k
Jeffrey L. Probstfield 4190 1174 1053 7 5.8k
Eugene Manley 5181 1370 1245 12 7.1k
KyungAh Im 3380 1337 1440 47 4.5k
Kirstine Brown‐Frandsen 5369 2087 1854 7 6.2k
Honora H. McElroy 5181 1364 1253 6 7.1k
Urszula Masiukiewicz 1932 873 1017 21 4.0k
Donna Wright 5670 1416 1331 8 7.8k

All Works

Loading papers...

Rankless by CCL
2026